Betmiga 50 mg 30 Tablets:
- Betmiga is a medicine that contains the active ingredient
- Available in the form of long-acting tablets (25 mg, 50 mg).
- Prolonged release means that mirabegron is slowly released from the tablet over a few hours.
- etmiga is used in adults with overactive bladder syndrome.
It is used to treat certain symptoms of the condition:
- Urgency (a sudden urgency to urinate), increased frequency of urination (the need to urinate frequently), and urge incontinence (involuntary leakage of urine from the bladder when a sudden, intense need to urinate is felt).
- The medicine can only be obtained with a prescription.
Instructions for use:
- The recommended dose of Betmiga is 50 mg once a day.
- In patients with impaired kidney or liver function, the doctor may need to prescribe a lower dose or avoid the use of Betmiga, especially in patients taking certain other medications.
Warnings and precautions:
Do not take BETMIGA if you are allergic to:
- Any medicine containing mirabegron
Some allergy symptoms may include:
- shortness of breath.
- Wheezing or difficulty breathing.
- Swelling of the face, lips, tongue, or other parts of the body.
- Rash, itching or hives on the skin.
Do not take BETMIGA:
- If you have very high blood pressure (systolic greater than or equal to 180 mmHg and/or diastolic greater than or equal to 110 mmHg).
- If you are not sure whether you should start taking this medicine, talk to your doctor.
- Before you start taking it
- Tell your doctor if you are allergic to any other medications, foods, preservatives, or dyes.
Tell your doctor if you have or have ever had any of the following medical conditions:
- Kidney problems.
- Liver problems.
- high blood pressure.
- Heart disorders, including arrhythmias, an abnormal electrical signal in the heart that can cause an irregular heartbeat called 'QT prolongation', or if you are taking any medicine known to cause an irregular heartbeat (see 'Taking medicines Other" medicines)
- Difficulty emptying your bladder or have a weak urethra
- Tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Your doctor can discuss with you the risks and benefits involved.
the components:
- Betmiga 25 mg long-acting tablets.
- Betmiga 50 mg extended release tablets.